BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Dec. 15, 2005
View Archived Issues
Amgen Offers To Buy Out Abgenix For $2.2B In Cash
In what could become one of the top acquisitions of 2005, Amgen Inc. offered to acquire Abgenix Inc. for $22.50 a share - or about $2.2 billion in cash. (BioWorld Today)
Read More
Zadaxin Phase III Miss Drops SciClone's Stock 40 Percent
Read More
Arena's Obesity Drug Yields Positive Results In Phase IIb
Read More
Optimer Brings In $34.2M To Advance Anti-Infectives
Read More
ActivBiotics, Metaphore Merge With Two Late-Stage Therapies
Read More
Human Genome Sciences Spinning Out CoGenesys
Read More
Other News To Note
Read More